123 related articles for article (PubMed ID: 22034855)
1. Effects of a new hemostatic agent Ankaferd Blood Stopper(®)on the intraocular tissues in rat model.
Alpay A; Bektas S; Alpay A; Ugurbas SC; Evren C; Ugurbas SH
Cutan Ocul Toxicol; 2012 Jun; 31(2):128-31. PubMed ID: 22034855
[TBL] [Abstract][Full Text] [Related]
2. Effects of the folk medicinal plant extract Ankaferd Blood Stopper® on the ocular surface.
Alpay A; Evren C; Bektaş S; Ugurbas SC; Ugurbas SH; Cınar F
Cutan Ocul Toxicol; 2011 Dec; 30(4):280-5. PubMed ID: 21425951
[TBL] [Abstract][Full Text] [Related]
3. Use of a novel haemostatic agent: ankaferd blood stopper in conjunctival incisions.
Alpay A; Ugurbas SC; Evren C; Bektas S; Calıskan S; Ugurbas SH
Clin Exp Ophthalmol; 2011 Nov; 39(8):793-8. PubMed ID: 21631678
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model.
Iynen I; Sogut O; Kose R
Otolaryngol Head Neck Surg; 2011 Nov; 145(5):840-4. PubMed ID: 21750339
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model.
Taş A; Köklü S; Beyazit Y; Karaca G; Astarcı HM; Akbal E; Koçak E; Topçu G; Haznedaroglu IC
Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):549-53. PubMed ID: 21489900
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the hemostatic and histopathological effects of Ankaferd Blood Stopper in experimental liver injury in rats.
Satar NY; Akkoc A; Oktay A; Topal A; Inan K
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):518-24. PubMed ID: 23399904
[TBL] [Abstract][Full Text] [Related]
7. [Modulation of expression of platelet-derived growth factor by nuclear transcription factor-kappaB in rats retina].
Mo B; Liu W; Yang L; Jiao J
Zhonghua Yan Ke Za Zhi; 2007 Jan; 43(1):49-54. PubMed ID: 17442164
[TBL] [Abstract][Full Text] [Related]
8. The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats.
Lemaitre C; Thillaye-Goldenberg B; Naud MC; de Kozak Y
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2022-30. PubMed ID: 11481267
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, Ankaferd Blood Stopper, on vascular tissue in a rat aortic bleeding model.
Kandemir O; Buyukates M; Kandemir NO; Aktunc E; Gul AE; Gul S; Turan SA
J Cardiothorac Surg; 2010 Nov; 5():110. PubMed ID: 21073754
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer with liposomes to the intraocular tissues by different routes of administration.
Masuda I; Matsuo T; Yasuda T; Matsuo N
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1914-20. PubMed ID: 8759362
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial.
Huri E; Akgül T; Ayyildiz A; Ustün H; Germiyanoğlu C
J Urol; 2009 May; 181(5):2349-54. PubMed ID: 19303089
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model.
Bilgili H; Kosar A; Kurt M; Onal IK; Goker H; Captug O; Shorbagi A; Turgut M; Kekilli M; Kurt OK; Kirazli S; Aksu S; Haznedaroglu IC
Med Princ Pract; 2009; 18(3):165-9. PubMed ID: 19349716
[TBL] [Abstract][Full Text] [Related]
13. Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial.
Kilic O; Gonen M; Acar K; Yurdakul T; Avunduk MC; Esen HH; Oz M
BJU Int; 2010 Jun; 105(12):1722-5. PubMed ID: 19849692
[TBL] [Abstract][Full Text] [Related]
14. Medicinal plant extract (Ankaferd Blood Stopper) application in deep tissue injuries in rats: histopathological investigation of the effect on regional and systemic tissues.
Okumuş M; Yüksel KZ; Özbağ D; Çıralık H; Yılmaz Z; Gümüşalan Y; Bakan V; Kalender AM
Ulus Travma Acil Cerrahi Derg; 2013 Jan; 19(1):1-7. PubMed ID: 23588971
[TBL] [Abstract][Full Text] [Related]
15. Toxicity study of erucylphosphocholine in a rat model.
Schuettauf F; Eibl KH; Thaler S; Shinoda K; Rejdak R; May CA; Blatsios G; Welge-Lussen U
Curr Eye Res; 2005 Sep; 30(9):813-20. PubMed ID: 16146926
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
Kosar A; Cipil HS; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Ercetin S; Kirazli S; Firat HC
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):185-90. PubMed ID: 19657315
[TBL] [Abstract][Full Text] [Related]
17. Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis.
Gwon A; Mantras C; Gruber L; Cunanan C
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3483-8. PubMed ID: 8258503
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new hemostatic agent Ankaferd Blood Stopper in experimental liver laceration.
Karakaya K; Ucan HB; Tascilar O; Emre AU; Cakmak GK; Irkorucu O; Ankarali H; Comert M
J Invest Surg; 2009; 22(3):201-6. PubMed ID: 19466658
[TBL] [Abstract][Full Text] [Related]
19. Intraarticular Ankaferd blood stopper application increases cartilagedegeneration: an experimental study.
Kaya İ; Gülabi D; Yilmaz M; Baş A; Çeçen GS; Şener N
Turk J Med Sci; 2016 Jan; 46(1):236-40. PubMed ID: 27511359
[TBL] [Abstract][Full Text] [Related]
20. Hemostatic efficacy of a traditional medicinal plant extract (Ankaferd Blood Stopper) in bleeding control.
Sogut O; Erdogan MO; Kose R; Boleken ME; Kaya H; Gokdemir MT; Ozgonul A; Iynen I; Albayrak L; Dokuzoglu MA
Clin Appl Thromb Hemost; 2015 May; 21(4):348-53. PubMed ID: 24057394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
